A Multilayer Cryogel Platform for the Spatiotemporally Controlled Release of Protein Cargo
Journal of Biomedical Materials Research Part A · 2026-12 · 114 (12)
DOI: 10.1002/jbm.a.70197 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biomedical Materials Research Part A, online erschienen am 17.11.2026. Verfasst von Sydney Henriques und 3 weiteren Autor:innen. Die Arbeit nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Vanderbilt University, Congressionally Directed Medical Research Programs.
Abstract (Originalsprache)
Biomaterial‐mediated drug delivery systems can improve therapeutic efficacy by extending local drug retention and reducing the need for repeated administration compared to bolus delivery of unformulated therapeutics. Cryogels are macroporous, crosslinked polymer networks capable of releasing hydrophilic cargos; however, many cryogel systems exhibit substantial burst release, resulting in rapid cargo loss. This study investigated whether modifying cryogel architecture through multilayer design of a macro‐sized cryogel could reduce burst release and provide tunable release kinetics while proposing new capabilities such as sequential release of multiple cargoes. Single‐, double‐, and triple‐layer methacrylate‐alginate cryogels were fabricated with fluorescent IgG Fab fragments as cargo localized within a central core layer and surrounded by one or more outer diffusion‐barrier layers. Release profiles were analyzed using the Korsmeyer–Peppas model to characterize early‐stage release and the Weibull model to assess full release behavior. Increasing layer number progressively reduced burst release and prolonged release duration. Approximated times required to achieve 50% cumulative release ( t 50 ) increased from 4.3 h for single‐layer cryogels to 19.9 and 43.3 h for double‐ and triple‐layer cryogels, respectively, demonstrating substantial control over release kinetics through architectural design. Model fitting further revealed systematic changes in release parameters associated with increasing architectural complexity, indicating that cryogel structure can be used to slow and delay release kinetics. To facilitate the rational design of future delivery systems, we developed a new correlation using the Weibull parameters that accurately predicted protein release performance in higher‐order multilayer cryogels. A preliminary prediction of triple‐layer cryogel release based on Weibull parameters obtained from single‐ and double‐layer systems showed agreement with the experimentally measured profile, with a mean absolute error of 4.7 percentage points in fractional release. These findings support further investigation of empirical release models as tools for guiding multilayer cryogel design, although additional independent validation is needed. Collectively, these findings demonstrate that multilayer cryogel architecture provides a simple yet effective strategy for controlling therapeutic release and highlight the utility of extending existing mathematical models for predicting and optimizing biomaterial‐mediated drug delivery systems.
Förderung
- Vanderbilt University
- Congressionally Directed Medical Research Programs
Zitieren
APA
Henriques, S., Amuluru, A., Chalom, O., & Giorgio, T. (2026). A Multilayer Cryogel Platform for the Spatiotemporally Controlled Release of Protein Cargo. Journal of Biomedical Materials Research Part A, 114(12). https://doi.org/10.1002/jbm.a.70197
Vancouver
Henriques S, Amuluru A, Chalom O, Giorgio T. A Multilayer Cryogel Platform for the Spatiotemporally Controlled Release of Protein Cargo. Journal of Biomedical Materials Research Part A. 2026;114(12). doi:10.1002/jbm.a.70197
BibTeX
@article{Henriques2026,
author = {Henriques, Sydney and Amuluru, Abhinav and Chalom, Ori and Giorgio, Todd},
title = {A Multilayer Cryogel Platform for the Spatiotemporally Controlled Release of Protein Cargo},
journal = {Journal of Biomedical Materials Research Part A},
year = {2026},
volume = {114},
number = {12},
doi = {10.1002/jbm.a.70197}
}
EUVIMED